跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COAPROVEL 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
COAPROVEL 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
COAPROVEL 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Sanofi-Aventis Groupe
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 29, 2020
Approval ID
398ef390e3bcc5c8
Company
Sanofi-Aventis Groupe
Type
Standard
Approval Details
Approval Id
398ef390e3bcc5c8
Drug Cima Aemps Name
COAPROVEL 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
98086017IP3
Holder Company Name
Sanofi-Aventis Groupe
Marketing Company Name
Ecofar Productos S.L.
Holder Company Detail Path
/organization/sanofi-aventis-groupe
Authorization Date
2020-05-29
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
300 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sanofi-Aventis Groupe
Company Detail Path
/organization/sanofi-aventis-groupe
Company Information
Pharmaceutical Company Name
Sanofi-Aventis Groupe
Name En
Sanofi-Aventis Groupe
Country Name
France
City Name
paris,ile de france,country_fr
Address
174 AVENUE DE FRANCE
Active Ingredients
IRBESARTAN
300 mg
HIDROCLOROTIAZIDA
12,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 29, 2020
Approval ID
398ef390e3bcc5c8
Type
Standard
Back to CIMA-AEMPS Approvals